Why are potato chips still so expensive?
In recent years, an increasing number of consumers have been abandoning their favorite brand-name potato chips for cheaper, generic options. That's because chip prices are on the rise, primarily due to inflation (one could call it 'potato-flation,' even) and extreme weather.
Last July, Matt Phillips of Sherwood News reported that 'prices for a 16-ounce bag of chips are up 30.6% since the end of 2020, outpacing the 20.6% increase in the consumer price index.' That's roughly 'a decade to 15 years worth of price increases in around three years,' Phillips added, considering that price increases for potato chips 'have typically been between 1%-2% a year.'
'Shoppers are no longer willing to swallow high prices for brand-name potato chips, and salty snack makers are loath to roll back the highly profitable price increases of recent years,' Phillips wrote in a report titled 'High-priced potato chips are ticking off Americans.'
That trend prevails in the new year as potato chip prices continue to skyrocket nationwide. Ten years ago, the average price for a 16-ounce bag of chips was $4.27, according to the U.S. Bureau of Labor Statistics. By the end of 2024, it was $6.32. The price hikes are, in part, due to inflation. Per the U.S. Department of Agriculture (USDA), the all-items Consumer Price Index (CPI) for food increased 0.6% from December 2024 to January 2025. And food prices, overall, were up 2.5% in January 2025 compared to last year. But climate change is also a factor in driving the high cost of potatoes.
As of 2024, Idaho (which produced 32% of the crop, according to Potato News Today) and Washington (which produced 24% of the crop) remain the top two potato-producing states in the country. However, warmer weather has been threatening potato production in both states. Idaho experienced its third warmest year on record in 2024, while Washington had its 15th warmest year, according to The Cool Down, an online news source covering all things climate and sustainability.
The impact of rising temperatures on the snack industry is best seen in Pennsylvania, where there are 'more potato chip factories than any other state in the Union,' Nathan Tallman, CEO of the Pennsylvania Cooperative Potato Growers, told The Allegheny Front. Unlike Idaho and Washington, Pennsylvania does not produce the bulk of potatoes in the U.S. But chip-makers based in the state prefer getting the crop from local farmers, especially in the wake of inflation and high transportation costs.
'It's cheaper to ship potatoes from farms in Pennsylvania to, say, Hanover [Snyder's of Hanover snack company, based in Pennsylvania] versus coming from Florida, Michigan or Alliston, Ontario,' Tallman explained.
Pennsylvania experienced its warmest year on record in 2024, meaning potatoes were also difficult to grow. Potatoes grow best in cool weather, when soil temperatures are between 60 to 65 degrees Fahrenheit during the day. They'll stop growing completely if the soil reaches 85 degrees. According to the Pennsylvania State Climatologist at Penn State University, daytime temperatures in Pennsylvania have been at 85 degrees or above in recent decades in many parts of the state.'If the climate is changing, and changing kind of rapidly, we have to develop potatoes that are adapted to the new climate,' Walter DeJong, a professor at Cornell University, told The Allegheny Front. DeJong added that it's not sustainable for Pennsylvania chip-makers to rely on potatoes from Florida and the northwest.
'Do they have the water to sustainably use to grow all those potatoes indefinitely out West?' he asked. 'I think the answer to that is 'no.' There's increasing water use issues in the West.'
In the wake of rising potato chip prices, more consumers have been turning to private-label, less-expensive store brand options. The New York Times reported back in October 2023 that 'private-label foods and beverages have crept up to a 20.6 % share of grocery dollars from 18.7% before the pandemic,' citing market research from Circana.
Potato chips are just another food item that inflation-weary consumers are either abandoning or seeking cheaper alternatives for. Consumers did the same with fast food which led to several chains, including McDonald's, Burger King and Wendy's to release their own rendition of value meals.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Media Advisory - Canada's municipal, labour and business leaders respond to latest U.S. tariff hike threat
OTTAWA, ON, June 3, 2025 /CNW/ - The Federation of Canadian Municipalities, the Canadian Labour Congress, and the Canadian Chamber of Commerce will respond to the latest threat of doubling tariffs on Canadian aluminum and steel by the U.S. administration. The ongoing trade war and constant threat of tariffs continue to impact everyone, including Americans. At this crucial moment, Canada's municipal, workers and businesses are united in their fight to oppose these harmful tariffs. Amid this economic uncertainty, it's time to modernize how we work together as governments—starting with a new model that matches ambition with capacity. That's why FCM is calling for a National Prosperity Partnership: a coordinated plan to align infrastructure, housing, and investment with Canada's economic goals. Where: Press Conference Room 135-B, West Block, Parliament Hill When: Wednesday, June 4, at 1:00 p.m. ET Participants: Carole Saab, CEO, Federation of Canadian Municipalities Bea Bruske, President, Canadian Labour Congress Candace Laing, CEO and President, Canadian Chamber of Commerce Notes for media: All times are local Media are encouraged to arrive 15 minutes early to set up Please contact media@ to register The Federation of Canadian Municipalities is the national voice of municipal governments, with more than 2000 members representing more than 92 percent of the Canadian population. SOURCE Federation of Canadian Municipalities (FCM) View original content to download multimedia:
Yahoo
39 minutes ago
- Yahoo
USDA announces $1 billion relief to livestock producers impacted by disasters
WASHINGTON, D.C. (KFOR) – Livestock producers in Oklahoma impacted by drought or wildfires in 2023 and 2024 are in line for relief according to U.S. Department of Agriculture (USDA). The USDA's Farm Service Agency (FSA) is now providing $1 billion to livestock producers impacted by drought or wildfires in 2023 and 2024. USDA officials say, producers can expect payments to be streamlined and are automatically issued to those who have an approved LFP application on file for 2023 and/or 2024. Wall Street rises as most financial markets worldwide hold steady 'The Department of Agriculture is stepping up to support livestock producers by expediting disaster payments when drought and wildfires strike. Under President Trump's leadership, USDA has the backs of ranchers, and that's why we are delivering much-needed emergency relief ahead of schedule,' said Secretary Rollins. According to USDA, The American Relief Act, 2025, provided funds for emergency relief payments to assist with eligible losses suffered by livestock producers. For more information on supplemental disaster assistance click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
39 minutes ago
- Yahoo
Opinion - The Medicare device coverage gap delays life-saving treatment for seniors
Imagine dying of thirst with a glass of water just out of reach. The analogy is extreme, but that is how helpless some patients feel when they can't access therapies approved to treat their deadly disease. That vulnerability is particularly acute for people aged 65 and older whose lives depend on access to advanced medical devices. This is due to the Centers for Medicare and Medicaid Services' current reimbursement policies that delay Medicare coverage of these groundbreaking therapies because they are administered by a device, not a pill or a syringe. Over the last decade, there has been a welcomed emergence of cutting-edge medical devices that treat a wide range of chronic diseases — including glioblastoma, a deadly brain cancer with a significantly poor prognosis. These groundbreaking technologies put patients in control of their care by providing them with the freedom to receive the treatments they need from the comfort and convenience of their many cases, the Food and Drug Administration has recognized the importance of these therapies by approving them for patient use. However, CMS' reimbursement policies for medical devices continue to prevent many of these same patients from gaining timely access to those treatments. As it stands, there is a nearly five-year gap between when a new medical device receives FDA approval and is subsequently covered by Medicare. This is time that many patients diagnosed with hard-to-treat cancers do not have. Modernizing the reimbursement framework for new FDA-approved medical devices would provide patients access to game-changing treatments that can improve their overall quality of life and give them more time with their friends and family. Nothing can prepare you for the heartbreaking news that you or a loved one has been diagnosed with a primary or metastatic brain tumor. Yet, this is the reality for the 1.3 million Americans living with this devastating disease. Throughout my own battle with cancer, I was blessed to have friends and family by my side as I underwent treatment. Their support was critical to my survival, and that experience continues to inspire my commitment to patients who deserve unrestricted access to innovative therapies that can extend and improve their lives. Washington leaders are broadly in agreement over the need to close this gap in coverage. The previous administration tried to fix it by releasing the long-awaited Transitional Coverage for Emerging Technologies pathway last year. Unfortunately, it fell well short of patients' expectations. Among other things, it forced most devices through the National Coverage Determination pathway, which does not guarantee a faster review. It also capped the number of devices eligible for expedited Medicare coverage to five annually. A bipartisan group of lawmakers likewise attempted to solve the problem. They introduced common-sense legislation that would have eliminated the five-product maximum under Transitional Coverage for Emerging Technologies and ensured that all new FDA-approved medical devices are instantly covered by Medicare. It garnered robust support in both chambers, passing out of the House Ways and Means Committee before running out of time to advance in the Senate. Thankfully, Sens. Todd Young (R-Ind.) and Alex Padilla (D-Calif.) have recently teamed up in the 119th Congress to introduce the bipartisan Ensuring Patient Access to Critical Breakthrough Products Act of 2025, which seeks to streamline Medicare's regulatory process, cutting red tape and strengthening access to proven therapies for seniors. Far too many seniors are being told to wait, not because the necessary treatments don't exist but because Medicare's reimbursement policies have overlooked the critical treatment timeline and failed to keep pace with innovation. Looking ahead, Congress must prioritize the passage of this pivotal legislation so that patients have unobstructed access to innovative treatment options that the FDA has deemed safe and effective. In the fight against cancer, patients should have access to every approved therapy. Refusing to cover groundbreaking treatments is like putting hope just out of reach. Kelly Sitkin is the president and chief executive officer of the American Brain Tumor Association, the first national advocacy organization dedicated solely to brain tumors. ABTA is an advocacy partner of Novocure, the maker of the Tumor Treating Fields therapy. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.